secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2023-12-13T23:59:59+00:00
Accession:  0001140361-23-057478
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharmaceuticals appoints R. Keith Woods to Board of Directors
--------------------------------------------------------------------

- Appointed R. Keith Woods, former COO of argenx SE, to the Board effective December 7, 2023.
- Granted options to purchase 20,522 shares (3-year monthly vest) and 11,960 shares (1-year cliff vest).
- Woods has 30+ years biopharma experience; previously SVP North American operations at Alexion, managed $1B+ annual sales.
- No arrangements or family relationships disclosed; standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036123057478/0001140361-23-057478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036123057478/ef20016480_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-057478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer